Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study.
A fixed-dose combination of nifedipine gastrointestinal therapy system and candesartan cilexetil in patients with moderate-to-severe essential hypertension : an open-label, long-term safety and efficacy study.